10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001099800-23-000034 |
| Period End Date | 20230630 |
| Filing Date | 20230728 |
| Fiscal Year | 2023 |
| Fiscal Period | Q2 |
| XBRL Instance | ew-20230630_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
100 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$7.90M | USD | Point-in-time |
| Allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$8.10M | USD | Point-in-time |
| Preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50.00M | shares | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
50.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.04B | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$769.00M | USD | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Short-term investments (Note 4) |
ShortTermInvestments
|
$466.70M | USD | Point-in-time |
| Short-term investments (Note 4) |
ShortTermInvestments
|
$446.30M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Accounts receivable, net of allowances of $8.1 and $7.9, respectively |
AccountsReceivableNetCurrent
|
$754.40M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Accounts receivable, net of allowances of $8.1 and $7.9, respectively |
AccountsReceivableNetCurrent
|
$643.00M | USD | Point-in-time |
| Other receivables |
OtherReceivables
|
$56.10M | USD | Point-in-time |
| Other receivables |
OtherReceivables
|
$62.50M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
1.05B | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
1.05B | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
646.30M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
649.10M | shares | Point-in-time |
| Inventories (Note 2) |
InventoryNet
|
$980.20M | USD | Point-in-time |
| Inventories (Note 2) |
InventoryNet
|
$875.50M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
608.30M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
607.90M | shares | Point-in-time |
| Prepaid expenses |
PrepaidExpenseCurrent
|
$110.00M | USD | Point-in-time |
| Prepaid expenses |
PrepaidExpenseCurrent
|
$123.20M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$217.40M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$195.90M | USD | Point-in-time |
| Treasury stock (in shares) |
TreasuryStockCommonShares
|
38.00M | shares | Point-in-time |
| Treasury stock (in shares) |
TreasuryStockCommonShares
|
41.20M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$3.10B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$3.65B | USD | Point-in-time |
| Long-term investments (Note 4) |
LongTermInvestments
|
$1.24B | USD | Point-in-time |
| Long-term investments (Note 4) |
LongTermInvestments
|
$856.20M | USD | Point-in-time |
| Property, plant, and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.63B | USD | Point-in-time |
| Property, plant, and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.66B | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$84.90M | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$92.30M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$1.30B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$1.16B | USD | Point-in-time |
| Other intangible assets, net (Note 6) |
IntangibleAssetsNetExcludingGoodwill
|
$431.40M | USD | Point-in-time |
| Other intangible assets, net (Note 6) |
IntangibleAssetsNetExcludingGoodwill
|
$285.20M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$610.70M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$484.00M | USD | Point-in-time |
| Other assets (Note 5) |
OtherAssetsNoncurrent
|
$412.10M | USD | Point-in-time |
| Other assets (Note 5) |
OtherAssetsNoncurrent
|
$299.10M | USD | Point-in-time |
| Total assets |
Assets
|
$8.29B | USD | Point-in-time |
| Total assets |
Assets
|
$9.00B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$201.90M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$193.00M | USD | Point-in-time |
| Accrued and other liabilities (Note 2) |
AccruedAndOtherLiabilitiesCurrent
|
$939.90M | USD | Point-in-time |
| Accrued and other liabilities (Note 2) |
AccruedAndOtherLiabilitiesCurrent
|
$795.00M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$24.30M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$25.50M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$1.16B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$1.02B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$596.30M | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$596.70M | USD | Point-in-time |
| Contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
- | USD | Point-in-time |
| Contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
$26.20M | USD | Point-in-time |
| Taxes payable |
TaxesPayableCurrentAndNoncurrent
|
$81.20M | USD | Point-in-time |
| Taxes payable |
TaxesPayableCurrentAndNoncurrent
|
$143.40M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$69.50M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$63.50M | USD | Point-in-time |
| Uncertain tax positions |
LiabilityForUncertainTaxPositionsNoncurrent
|
$303.70M | USD | Point-in-time |
| Uncertain tax positions |
LiabilityForUncertainTaxPositionsNoncurrent
|
$267.50M | USD | Point-in-time |
| Litigation settlement accrual (Note 2) |
LitigationReserveNoncurrent
|
$112.50M | USD | Point-in-time |
| Litigation settlement accrual (Note 2) |
LitigationReserveNoncurrent
|
$143.00M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$217.50M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$242.70M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$2.56B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$2.49B | USD | Point-in-time |
| Commitments and contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $1.00 par value, 1,050.0 shares authorized, 649.1 and 646.3 shares issued, and 607.9 and 608.3 shares outstanding, respectively |
CommonStockValue
|
$646.30M | USD | Point-in-time |
| Common stock, $1.00 par value, 1,050.0 shares authorized, 649.1 and 646.3 shares issued, and 607.9 and 608.3 shares outstanding, respectively |
CommonStockValue
|
$649.10M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$1.97B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$2.15B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$8.24B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$7.59B | USD | Point-in-time |
| Accumulated other comprehensive loss (Note 12) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-255.50M | USD | Point-in-time |
| Accumulated other comprehensive loss (Note 12) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-254.90M | USD | Point-in-time |
| Treasury stock, at cost, 41.2 and 38.0 shares, respectively |
TreasuryStockCommonValue
|
$4.14B | USD | Point-in-time |
| Treasury stock, at cost, 41.2 and 38.0 shares, respectively |
TreasuryStockCommonValue
|
$4.40B | USD | Point-in-time |
| Total Edwards Lifesciences Corporation stockholders' equity |
StockholdersEquity
|
$6.38B | USD | Point-in-time |
| Total Edwards Lifesciences Corporation stockholders' equity |
StockholdersEquity
|
$5.81B | USD | Point-in-time |
| Noncontrolling interest (Note 6) |
MinorityInterest
|
- | USD | Point-in-time |
| Noncontrolling interest (Note 6) |
MinorityInterest
|
$70.80M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.94B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.81B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.45B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.06B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$8.29B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$9.00B | USD | Point-in-time |
Income Statement
78 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.37B | USD | 1 Quarter |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.53B | USD | 1 Quarter |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$2.72B | USD | 2 Qtrs |
| Net sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$2.99B | USD | 2 Qtrs |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$269.40M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$672.50M | USD | 2 Qtrs |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$343.00M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$568.70M | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$2.32B | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$2.15B | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$1.10B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$1.19B | USD | 1 Quarter |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$468.70M | USD | 1 Quarter |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$905.00M | USD | 2 Qtrs |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$409.00M | USD | 1 Quarter |
| Selling, general, and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$779.30M | USD | 2 Qtrs |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$250.80M | USD | 1 Quarter |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$270.30M | USD | 1 Quarter |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$531.50M | USD | 2 Qtrs |
| Research and development expenses |
ResearchAndDevelopmentExpense
|
$479.40M | USD | 2 Qtrs |
| Intellectual property agreement and litigation expense (Note 3) |
LitigationSettlementExpense
|
$147.90M | USD | 1 Quarter |
| Intellectual property agreement and litigation expense (Note 3) |
LitigationSettlementExpense
|
$191.40M | USD | 2 Qtrs |
| Intellectual property agreement and litigation expense (Note 3) |
LitigationSettlementExpense
|
$13.20M | USD | 2 Qtrs |
| Intellectual property agreement and litigation expense (Note 3) |
LitigationSettlementExpense
|
$6.10M | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-26.20M | USD | 2 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-20.90M | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-23.80M | USD | 2 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-26.90M | USD | 1 Quarter |
| Operating income, net |
OperatingIncomeLoss
|
$327.20M | USD | 1 Quarter |
| Operating income, net |
OperatingIncomeLoss
|
$459.50M | USD | 1 Quarter |
| Operating income, net |
OperatingIncomeLoss
|
$715.60M | USD | 2 Qtrs |
| Operating income, net |
OperatingIncomeLoss
|
$898.30M | USD | 2 Qtrs |
| Interest income, net |
InterestIncomeExpenseNet
|
$1.50M | USD | 2 Qtrs |
| Interest income, net |
InterestIncomeExpenseNet
|
$17.70M | USD | 2 Qtrs |
| Interest income, net |
InterestIncomeExpenseNet
|
$900.00K | USD | 1 Quarter |
| Interest income, net |
InterestIncomeExpenseNet
|
$9.10M | USD | 1 Quarter |
| Other income, net |
OtherNonoperatingIncomeExpense
|
$4.30M | USD | 1 Quarter |
| Other income, net |
OtherNonoperatingIncomeExpense
|
$2.20M | USD | 1 Quarter |
| Other income, net |
OtherNonoperatingIncomeExpense
|
$1.00M | USD | 2 Qtrs |
| Other income, net |
OtherNonoperatingIncomeExpense
|
$3.80M | USD | 2 Qtrs |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$464.70M | USD | 1 Quarter |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$338.50M | USD | 1 Quarter |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$900.80M | USD | 2 Qtrs |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$737.10M | USD | 2 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$91.10M | USD | 2 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$58.30M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$33.00M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$120.80M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$780.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$646.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net loss attributable to noncontrolling interest (Note 6) |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Net loss attributable to noncontrolling interest (Note 6) |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.60M | USD | 1 Quarter |
| Net loss attributable to noncontrolling interest (Note 6) |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 2 Qtrs |
| Net loss attributable to noncontrolling interest (Note 6) |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.60M | USD | 2 Qtrs |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$647.60M | USD | 2 Qtrs |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$307.10M | USD | 1 Quarter |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$406.40M | USD | 1 Quarter |
| Net income attributable to Edwards Lifesciences Corporation |
NetIncomeLoss
|
$780.00M | USD | 2 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$1.07 | USD | 2 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$1.26 | USD | 2 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.51 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.65 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$1.24 | USD | 2 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$1.06 | USD | 2 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.65 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.50 | USD | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
607.20M | shares | 2 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
621.50M | shares | 2 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
620.90M | shares | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
606.90M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
610.60M | shares | 2 Qtrs |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
628.10M | shares | 2 Qtrs |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
626.70M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
610.30M | shares | 1 Quarter |
Cash Flow Statement
82 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$780.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$646.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$71.30M | USD | 2 Qtrs |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$68.80M | USD | 2 Qtrs |
| Non-cash operating lease cost |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$13.70M | USD | 2 Qtrs |
| Non-cash operating lease cost |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$13.90M | USD | 2 Qtrs |
| Stock-based compensation (Note 9) |
ShareBasedCompensation
|
$76.30M | USD | 2 Qtrs |
| Stock-based compensation (Note 9) |
ShareBasedCompensation
|
$68.60M | USD | 2 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-20.90M | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-23.80M | USD | 2 Qtrs |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-26.90M | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities (Note 7) |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-26.20M | USD | 2 Qtrs |
| Loss (gain) on investments, net |
GainLossOnInvestments
|
$-38.20M | USD | 2 Qtrs |
| Loss (gain) on investments, net |
GainLossOnInvestments
|
$3.50M | USD | 2 Qtrs |
| Deferred income taxes |
IncreaseDecreaseInDeferredIncomeTaxes
|
$102.40M | USD | 2 Qtrs |
| Deferred income taxes |
IncreaseDecreaseInDeferredIncomeTaxes
|
$134.70M | USD | 2 Qtrs |
| Other |
OtherNoncashIncomeExpense
|
$-2.80M | USD | 2 Qtrs |
| Other |
OtherNoncashIncomeExpense
|
$-4.20M | USD | 2 Qtrs |
| Accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$124.30M | USD | 2 Qtrs |
| Accounts and other receivables, net |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$77.70M | USD | 2 Qtrs |
| Inventories |
IncreaseDecreaseInInventories
|
$113.70M | USD | 2 Qtrs |
| Inventories |
IncreaseDecreaseInInventories
|
$85.80M | USD | 2 Qtrs |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$76.20M | USD | 2 Qtrs |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-81.70M | USD | 2 Qtrs |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$31.00M | USD | 2 Qtrs |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$49.70M | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$43.40M | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-25.70M | USD | 2 Qtrs |
| Intellectual property agreement accrual |
IncreaseDecreaseInLegalSettlementAccrual
|
$-14.50M | USD | 2 Qtrs |
| Intellectual property agreement accrual |
IncreaseDecreaseInLegalSettlementAccrual
|
$-19.70M | USD | 2 Qtrs |
| Long-term prepaid royalties (Note 3) |
IncreaseDecreaseInPrepaidRoyalties
|
$114.00M | USD | 2 Qtrs |
| Long-term prepaid royalties (Note 3) |
IncreaseDecreaseInPrepaidRoyalties
|
- | USD | 2 Qtrs |
| Other |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$32.50M | USD | 2 Qtrs |
| Other |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$-4.70M | USD | 2 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$347.70M | USD | 2 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$625.50M | USD | 2 Qtrs |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$115.80M | USD | 2 Qtrs |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$109.40M | USD | 2 Qtrs |
| Purchases of held-to-maturity investments (Note 4) |
PaymentsToAcquireHeldToMaturitySecurities
|
$15.50M | USD | 2 Qtrs |
| Purchases of held-to-maturity investments (Note 4) |
PaymentsToAcquireHeldToMaturitySecurities
|
$180.70M | USD | 2 Qtrs |
| Proceeds from held-to-maturity investments (Note 4) |
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
$83.50M | USD | 2 Qtrs |
| Proceeds from held-to-maturity investments (Note 4) |
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
$277.50M | USD | 2 Qtrs |
| Purchases of available-for-sale investments (Note 4) |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$6.80M | USD | 2 Qtrs |
| Purchases of available-for-sale investments (Note 4) |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$114.30M | USD | 2 Qtrs |
| Proceeds from available-for-sale investments (Note 4) |
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
$314.50M | USD | 2 Qtrs |
| Proceeds from available-for-sale investments (Note 4) |
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
$584.10M | USD | 2 Qtrs |
| Business combination, net of cash (Note 6) |
PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions
|
$141.20M | USD | 2 Qtrs |
| Business combination, net of cash (Note 6) |
PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions
|
- | USD | 2 Qtrs |
| Payment for acquisition options (Note 5) |
OtherPaymentsToAcquireBusinesses
|
$15.00M | USD | 2 Qtrs |
| Payment for acquisition options (Note 5) |
OtherPaymentsToAcquireBusinesses
|
$55.50M | USD | 2 Qtrs |
| Issuances of notes receivable |
PaymentsToAcquireReceivables
|
$45.50M | USD | 2 Qtrs |
| Issuances of notes receivable |
PaymentsToAcquireReceivables
|
$22.50M | USD | 2 Qtrs |
| Collections of notes receivable |
ProceedsFromCollectionOfNotesReceivable
|
- | USD | 2 Qtrs |
| Collections of notes receivable |
ProceedsFromCollectionOfNotesReceivable
|
$18.00M | USD | 2 Qtrs |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$16.90M | USD | 2 Qtrs |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$8.70M | USD | 2 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$70.70M | USD | 2 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$359.10M | USD | 2 Qtrs |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$760.70M | USD | 2 Qtrs |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$256.80M | USD | 2 Qtrs |
| Proceeds from stock plans |
ProceedsFromStockPlans
|
$86.50M | USD | 2 Qtrs |
| Proceeds from stock plans |
ProceedsFromStockPlans
|
$102.70M | USD | 2 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-400.00K | USD | 2 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-2.00M | USD | 2 Qtrs |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-676.20M | USD | 2 Qtrs |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-154.50M | USD | 2 Qtrs |
| Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$27.10M | USD | 2 Qtrs |
| Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$11.00M | USD | 2 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$274.90M | USD | 2 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$335.50M | USD | 2 Qtrs |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$867.40M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$772.60M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.20B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.05B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.20B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.05B | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$772.60M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$867.40M | USD | Point-in-time |
Stockholders Equity
44 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, beginning balance (in shares) |
CommonStockSharesOutstanding
|
608.30M | shares | Point-in-time |
| Common stock, beginning balance (in shares) |
CommonStockSharesOutstanding
|
607.90M | shares | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.94B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.81B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.45B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.06B | USD | Point-in-time |
| Treasury stock, beginning balance (in shares) |
TreasuryStockCommonShares
|
38.00M | shares | Point-in-time |
| Treasury stock, beginning balance (in shares) |
TreasuryStockCommonShares
|
41.20M | shares | Point-in-time |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$646.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$780.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-100.00K | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-28.90M | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-37.80M | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-500.00K | USD | 1 Quarter |
| Common stock issued under stock plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$37.50M | USD | 1 Quarter |
| Common stock issued under stock plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$60.80M | USD | 1 Quarter |
| Common stock issued under stock plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$41.90M | USD | 1 Quarter |
| Common stock issued under stock plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$49.00M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$36.20M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$37.40M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$38.90M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$32.40M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$405.60M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$249.50M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$7.50M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$355.10M | USD | 1 Quarter |
| Changes to noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$-11.60M | USD | 1 Quarter |
| Changes to noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$84.00M | USD | 1 Quarter |
| Common stock, ending balance (in shares) |
CommonStockSharesOutstanding
|
608.30M | shares | Point-in-time |
| Common stock, ending balance (in shares) |
CommonStockSharesOutstanding
|
607.90M | shares | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.94B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.81B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.45B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.84B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.06B | USD | Point-in-time |
| Treasury stock, ending balance (in shares) |
TreasuryStockCommonShares
|
38.00M | shares | Point-in-time |
| Treasury stock, ending balance (in shares) |
TreasuryStockCommonShares
|
41.20M | shares | Point-in-time |
Comprehensive Income
42 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$780.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$373.60M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$406.40M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$646.00M | USD | 2 Qtrs |
| Net income |
ProfitLoss
|
$340.50M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$305.50M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-43.20M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-53.20M | USD | 2 Qtrs |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-11.50M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-7.70M | USD | 2 Qtrs |
| Unrealized gain (loss) on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$31.30M | USD | 1 Quarter |
| Unrealized gain (loss) on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$5.30M | USD | 1 Quarter |
| Unrealized gain (loss) on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$-11.90M | USD | 2 Qtrs |
| Unrealized gain (loss) on hedges |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$44.70M | USD | 2 Qtrs |
| Unrealized pension credits (costs) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-100.00K | USD | 2 Qtrs |
| Unrealized pension credits (costs) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$100.00K | USD | 1 Quarter |
| Unrealized pension credits (costs) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-200.00K | USD | 1 Quarter |
| Unrealized pension credits (costs) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$100.00K | USD | 2 Qtrs |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$2.10M | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-30.90M | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$11.10M | USD | 2 Qtrs |
| Unrealized gain (loss) on available-for-sale investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-68.00M | USD | 2 Qtrs |
| Reclassification of realized investment losses to earnings |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$-3.80M | USD | 1 Quarter |
| Reclassification of realized investment losses to earnings |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$-5.10M | USD | 1 Quarter |
| Reclassification of realized investment losses to earnings |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$-9.90M | USD | 2 Qtrs |
| Reclassification of realized investment losses to earnings |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$-7.80M | USD | 2 Qtrs |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-37.80M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-600.00K | USD | 2 Qtrs |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-66.70M | USD | 2 Qtrs |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-100.00K | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$305.40M | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$645.40M | USD | 2 Qtrs |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$368.60M | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$713.30M | USD | 2 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 2 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-1.60M | USD | 2 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-1.60M | USD | 1 Quarter |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$368.60M | USD | 1 Quarter |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$307.00M | USD | 1 Quarter |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$713.30M | USD | 2 Qtrs |
| Comprehensive income attributable to Edwards Lifesciences Corporation |
ComprehensiveIncomeNetOfTax
|
$647.00M | USD | 2 Qtrs |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.